UK: Pharmacy Brief - June 2012

Last Updated: 12 June 2012
Article by David Reissner

Manchester Event

The CR Pharmacy Team will be taking to the stage again on 5 July 2012 at the Royal Exchange Theatre in Manchester. We will cover topics based on feedback from those of you who attended last year's conference:

  • Recent regulatory issues including exports and specials
  • Arrangements with GPs
  • Trends in pharmacy transactions
  • Market entry and market exit from 2012

The conference is free, subject to availability. To reserve a place, contact

Into the FoIA

We have seen an increase in the use of requests under the Freedom of Information Act to secure a commercial advantage. In appropriate cases, we have used them ourselves on behalf of clients. One PCT recently received a request for details of the number of prescription items dispensed by each pharmacy in its area for the last 24 months. We made detailed representations on behalf of a client as to why the information should not be supplied. The PCT declined to give the information.

PCT Demands that Pharmacy Stops Providing Services

Our client successfully applied for a NHS contract in his own name. Before opening, he formed a company which he registered with the GPhC as the owner of the pharmacy. When the PCT found out, it said that because the pharmacy was being operated by a company which was not on its pharmaceutical list, it was not entitled to provide, or be paid for, NHS pharmaceutical services. The PCT also referred the pharmacist to its performance panel, and said it was considering reporting the pharmacist to the GPhC. We managed to resolve these issues for the pharmacist; the pharmacy continues to trade, and the PCT has confirmed it will not take any further action. However, this pharmacist's experience reinforces the importance of getting specialist legal advice from the outset; because, if you get it wrong, you could lose your business.

Wales - Control of Entry

Wales did not follow suit when England made control of entry changes in 2005, so avoided the 100- hour debacle. The Welsh Assembly Government is now consulting on changes to its current regime, because it considers most applications are a waste of time and money.

The Assembly is now considering these proposals:

  • Future applications will depend on local PNAs
  • Repeat applications will be not be considered after a refusal
  • Fees will be introduced to discourage speculative applications
  • After preliminary consent has been granted, full applications will have to be submitted within a shorter time than at present
  • After a full application is granted, services must be provided within a shorter period
  • Minor relocations will be simplified but possibly with safeguards to prevent leapfrogging

Modernising Pharmacy Regulation

The GPhC's consultation on modernising pharmacy regulation ended on 7 May 2012. Here are some highlights:

  • Unlike its predecessor, the GPhC does not propose to lay down detailed standards.
  • The GPhC will no longer register premises that do not supply POMs or sell P medicines. This will have implications for some businesses operating a hub and spoke model
  • When pharmacies apply for registration, the GPhC may impose conditions, including a date by which the provision of services must commence
  • Where distance selling pharmacies are operated, a condition may be imposed that patients and the public are not permitted to visit
  • The GPhC expects registrants "to be familiar with all associated guidance", including its own.
  • On the upside, the GPhC will not regard legal enforcement as its first option to secure compliance. The downside is that compliance decisions will be made public
  • Separate guidance may be issued for internet pharmacies and for pharmacies relying on exemptions from the need for MHRA licences
  • As we announced in a previous issue of the Pharmacy Brief pharmacies will no longer be subject to a 3-year cycle of inspections

Out of Touch?

A GPhC Fitness to Practise Committee ruled that "a pharmacist is not competent to undertake a physical examination which includes the touching of a patient's body as part of a diagnostic procedure". Is that correct?

The answer is that it depends. For example, if a patient asks for advice about an itching eye, the pharmacist may need to touch the patient's face in the course of taking a closer look. For further details, ask us for a copy of David Reissner's Chemist & Druggist article on touching patients.

Want to Stay?

We were recently approached by the owner of a pharmacy in a health centre who wanted advice on the renewal of his expiring lease. The GPs are the landlords, and they said they would not grant a new lease to him. The Landlord and Tenant Act 1954 allows landlords to refuse to grant a new tenancy if landlords want to redevelop or to use the premises for their own business. When advising pharmacists who take a lease within health centres we recommend insisting on a right to renew the lease.

Need to Get Out?

A pharmacist's decision to move or practise from a health centre is often based on the number of prescriptions the GPs are likely to generate. If the GPs are no longer at the health centre, or the number of GPs falls, this could have a significant impact on the amount of business done by the pharmacy. When negotiating a new lease of a pharmacy in a health centre, pharmacists should think about including a break right in the lease, allowing them to terminate if circumstances at the health centre change.

It's a Deal

We are seeing more pharmacies coming onto the market than in 2011. This bears out feedback from delegates at our London Pharmacy Conferences in March this year. Recently completed transactions handled by Tim Jenkins and the Pharmacy Transactions Team include:-

  • Acting for Kevin Knightly and Cyril Howells on the sale of a Suffolk based pharmacy to Donald G Hayden (Chemists) Limited and associated property arrangements
  • Acting for Wricklemarsh Limited on its purchase of London based Jennings Chemist from Jennings (Chemist) Limited and associated property arrangements (sale brokered by Goldin Medical)
  • Acting for WM Brown (Kingshurst) Limited and Springpharm Limited in connection with their purchase from Boots UK Limited of shares in HHCC Limited (operator of a consortium pharmacy in Hinckley Health Centre - Leicestershire)
  • Acting for Deen & Co Limited on its purchase of Manchester based pharmacy operator D Machell (Wholesale) Limited
  • Acting for Julian and Jane Langer on the sale of London based pharmacy operator L & M Langer Limited to Meraj Limited and associated property arrangements (sale brokered by Hutchings Consultants)

Our understanding of pharmacy businesses enables us to offer a competitively priced, added value, full service for clients both large and small and whether buying or selling.

We can also offer a one-stop service by bringing in valuation and other expertise – for further details click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

David Reissner
In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions